16th & 17th NovemberManchester, UK

Innovation Sponsor

Online Market Place for R&D Outsourcing

Description: By enabling scientists to easily Outsource Everything but the Genius®, we are pioneering a faster, leaner and more innovation-centric approach to research. Our vision is to create a world in which scientists are limited only by their imagination.

Welcome

...to Biotech Outsourcing Strategies Manchester 2022

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

We are delighted to bring the BOS Events to the north of England and to a city synonymous with industrial and technological progression. BOS Manchester 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing. We look forward to welcoming you to the events new home in the heart of Manchester.

Resources for Sponsors & Attendees

Our valued sponsors can access our Getting started with your BOS Manchester Sponsorship - Step-by-step Guide. In addition, sponsors can refer to a summary of the Exhibition Logistics. Book your accommodation at BOS Manchester 2022 by clicking here.

Covid restrictions were lifted in the United Kingdom in early 2022.

Featured Speaker (BOS Manchester 2022)

Transitioning towards a Virtual CMC Operation for the Sourcing of API and Drug Products, Showcasing Highly Collaborative Outsourcing Partnerships

Dr Craig Harris, Head of Small Molecule Development & Scientific Advisor, Galderma

ABSTRACT: Over the few years, Galderma has undergone a huge transition from having internal R&D, supporting drug discovery and early development up to Phase II, to a fully externalized or virtual pharmaceutical company model. This talk will focus on how we adapted to this new operating model and optimized our workflows in the CMC department through a science-driven and highly collaborative approach with our supporting contract research and manufacturing organizations. Highlighted is a very recent example of a highly successful collaboration across 5 sites and 6 countries to identify compendial impurities... Click here to Read More

Featured Company (BOS Manchester 2022)

Lonza
At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing...
View profile